VOQUEZNA met its primary endpoint in its Phase 3 pivotal trial by demonstrating a significant and rapid reduction of heartburn with daily treatment VOQUEZNA represents the first major innovation in ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Phathom Pharmaceuticals’ Voquezna tablets 10 mg and 20 mg to treat erosive esophagitis, or ...

This leaflet answers some common questions about SALPRAZ HEARTBURN RELIEF. It does not contain all the available information. It does not take the place of talking to your pharmacist or doctor. The ...

Omeprazole ODT utilizes MelTech technology that allows the tablet to dissolve in the mouth without water. Perrigo announced the launch of store brand Omeprazole Delayed Release Orally Disintegrating ...

Ever felt an uncomfortable tightness or pain in your chest after a big bowl of chili or spicy takeout? It could be heartburn, which occurs when the acid in your stomach sloshes back up into your ...

Many people are familiar with the discomfort of indigestion, with 40 per cent of UK adults experiencing it, annually. But whether indigestion is a result of stress, eating-on-the-go, pregnancy or ...

Akums Drugs and Pharmaceuticals, largest India focused CDMO proudly introduces dual-action heartburn relief chewable tablet, combining famotidine, calcium carbonate, and magnesium hydroxide. This ...

Decongestants, heartburn pills and tablets to ease some of the more, let’s just say distressing digestive complaints: just three of the over-the-counter remedies we reach for when we’re feeling under ...

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on ...

Eating too much food too fast is the most common cause of occasional heartburn, says Samuel Klein, MD. But it’s not the only one. Certain foods, prescription medications, and stress can also trigger ...

FLORHAM PARK, N.J., July 18, 2024 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for ...